Top Institutions in Ophthalmology, Genetic Retinal Diseases
Leading institutions in this area combine expertise in inherited retinal diseases, clinical trials in gene and pharmacologic therapies, and translational research in retinal cell biology and genetics. They often lead multicenter clinical trials and have dedicated retinal dystrophy programs.
-
#1
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a global leader in inherited retinal disease research, with extensive clinical trial experience in Stargardt disease and gene therapy development. Their collaboration with Harvard Medical School provides strong translational research capabilities.
-
#2
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong focus on genetic retinal diseases, including Stargardt disease, with active involvement in clinical trials and gene therapy research. Their multidisciplinary approach integrates clinical care with cutting-edge research.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is recognized for its comprehensive inherited retinal disease program and participation in international Stargardt disease clinical trials. They have expertise in retinal imaging and novel therapeutic development.
-
#4
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields and UCL are internationally renowned for their pioneering work in gene therapy for retinal diseases, including Stargardt disease, and have led several early-phase clinical trials.
-
#5
National Eye Institute (NEI), NIH
Bethesda, MD
NEI supports and conducts foundational research and clinical trials on Stargardt disease, including gene therapy and pharmacologic approaches, and provides significant funding for translational research in retinal dystrophies.